within Pharmacolibrary.Drugs.ATC.D;

model D05AC01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.02,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Dithranol, also known as anthralin, is a topical medication primarily used in the treatment of psoriasis. It exerts antiproliferative and anti-inflammatory effects, making it effective for chronic plaque psoriasis. It is not commonly used today due to skin irritation and staining but remains approved and available in some countries for topical application.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic properties of dithranol following topical administration are extremely limited in published literature, as systemic absorption is negligible and mainly acts locally on the skin. No peer-reviewed pharmacokinetic model studies with specific parameters in humans were located.</p><h4>References</h4><ol><li><p>Tripathi, PK, et al., &amp; Kesharwani, P (2019). Dendrimer entrapped microsponge gel of dithranol for effective topical treatment. <i>Heliyon</i> 5(3) e01343–None. DOI:<a href=&quot;https://doi.org/10.1016/j.heliyon.2019.e01343&quot;>10.1016/j.heliyon.2019.e01343</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30957038/&quot;>https://pubmed.ncbi.nlm.nih.gov/30957038</a></p></li><li><p>Agrawal, U, et al., &amp; Jain, NK (2013). Hyperbranched dendritic nano-carriers for topical delivery of dithranol. <i>Journal of drug targeting</i> 21(5) 497–506. DOI:<a href=&quot;https://doi.org/10.3109/1061186X.2013.771778&quot;>10.3109/1061186X.2013.771778</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23594093/&quot;>https://pubmed.ncbi.nlm.nih.gov/23594093</a></p></li><li><p>Kadian, V, et al., &amp; Rao, R (2020). Dithranol: An Insight into its Novel Delivery Cargos for Psoriasis Management. <i>Current drug research reviews</i> 12(2) 82–96. DOI:<a href=&quot;https://doi.org/10.2174/2589977512666200525154954&quot;>10.2174/2589977512666200525154954</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32484107/&quot;>https://pubmed.ncbi.nlm.nih.gov/32484107</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D05AC01;
